Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma
肝动脉灌注化疗联合乐伐替尼和程序性死亡蛋白-1抑制剂:一种治疗高肿瘤负荷肝细胞癌的有前景的治疗方法
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.7105
Fu, Shumin; Xu, Yongkang; Mao, Ye; He, Mengting; Chen, Zhimeng; Huang, Shenglan; Li, Dan; Lv, Yaqin; Wu, Jianbing